Report Detail

Medical Devices & Consumables Global Injectable Viscosupplementation for Joint Market Growth 2022-2028

  • RnM4474658
  • |
  • 29 July, 2022
  • |
  • Global
  • |
  • 107 Pages
  • |
  • LPI(LP Information)
  • |
  • Medical Devices & Consumables

As the global economy mends, the 2021 growth of Injectable Viscosupplementation for Joint will have significant change from previous year. According to our (LP Information) latest study, the global Injectable Viscosupplementation for Joint market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Injectable Viscosupplementation for Joint market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Injectable Viscosupplementation for Joint market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Injectable Viscosupplementation for Joint market, reaching US$ million by the year 2028. As for the Europe Injectable Viscosupplementation for Joint landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Injectable Viscosupplementation for Joint players cover Sanofi, Anika Therapeutics, Seikagaku, and Zimmer Biomet, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Viscosupplementation for Joint market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Single Injection
Three Injection
Five Injection

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Injectable Viscosupplementation for Joint Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Injectable Viscosupplementation for Joint by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Injectable Viscosupplementation for Joint by Country/Region, 2017, 2022 & 2028
  • 2.2 Injectable Viscosupplementation for Joint Segment by Type
    • 2.2.1 Single Injection
    • 2.2.2 Three Injection
    • 2.2.3 Five Injection
  • 2.3 Injectable Viscosupplementation for Joint Sales by Type
    • 2.3.1 Global Injectable Viscosupplementation for Joint Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Injectable Viscosupplementation for Joint Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Injectable Viscosupplementation for Joint Sale Price by Type (2017-2022)
  • 2.4 Injectable Viscosupplementation for Joint Segment by Application
    • 2.4.1 Hospital
    • 2.4.2 Clinic
    • 2.4.3 Other
  • 2.5 Injectable Viscosupplementation for Joint Sales by Application
    • 2.5.1 Global Injectable Viscosupplementation for Joint Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Injectable Viscosupplementation for Joint Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Injectable Viscosupplementation for Joint Sale Price by Application (2017-2022)

3 Global Injectable Viscosupplementation for Joint by Company

  • 3.1 Global Injectable Viscosupplementation for Joint Breakdown Data by Company
    • 3.1.1 Global Injectable Viscosupplementation for Joint Annual Sales by Company (2020-2022)
    • 3.1.2 Global Injectable Viscosupplementation for Joint Sales Market Share by Company (2020-2022)
  • 3.2 Global Injectable Viscosupplementation for Joint Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Injectable Viscosupplementation for Joint Revenue by Company (2020-2022)
    • 3.2.2 Global Injectable Viscosupplementation for Joint Revenue Market Share by Company (2020-2022)
  • 3.3 Global Injectable Viscosupplementation for Joint Sale Price by Company
  • 3.4 Key Manufacturers Injectable Viscosupplementation for Joint Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Injectable Viscosupplementation for Joint Product Location Distribution
    • 3.4.2 Players Injectable Viscosupplementation for Joint Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Injectable Viscosupplementation for Joint by Geographic Region

  • 4.1 World Historic Injectable Viscosupplementation for Joint Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Injectable Viscosupplementation for Joint Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Injectable Viscosupplementation for Joint Annual Revenue by Geographic Region
  • 4.2 World Historic Injectable Viscosupplementation for Joint Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Injectable Viscosupplementation for Joint Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Injectable Viscosupplementation for Joint Annual Revenue by Country/Region
  • 4.3 Americas Injectable Viscosupplementation for Joint Sales Growth
  • 4.4 APAC Injectable Viscosupplementation for Joint Sales Growth
  • 4.5 Europe Injectable Viscosupplementation for Joint Sales Growth
  • 4.6 Middle East & Africa Injectable Viscosupplementation for Joint Sales Growth

5 Americas

  • 5.1 Americas Injectable Viscosupplementation for Joint Sales by Country
    • 5.1.1 Americas Injectable Viscosupplementation for Joint Sales by Country (2017-2022)
    • 5.1.2 Americas Injectable Viscosupplementation for Joint Revenue by Country (2017-2022)
  • 5.2 Americas Injectable Viscosupplementation for Joint Sales by Type
  • 5.3 Americas Injectable Viscosupplementation for Joint Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Injectable Viscosupplementation for Joint Sales by Region
    • 6.1.1 APAC Injectable Viscosupplementation for Joint Sales by Region (2017-2022)
    • 6.1.2 APAC Injectable Viscosupplementation for Joint Revenue by Region (2017-2022)
  • 6.2 APAC Injectable Viscosupplementation for Joint Sales by Type
  • 6.3 APAC Injectable Viscosupplementation for Joint Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Injectable Viscosupplementation for Joint by Country
    • 7.1.1 Europe Injectable Viscosupplementation for Joint Sales by Country (2017-2022)
    • 7.1.2 Europe Injectable Viscosupplementation for Joint Revenue by Country (2017-2022)
  • 7.2 Europe Injectable Viscosupplementation for Joint Sales by Type
  • 7.3 Europe Injectable Viscosupplementation for Joint Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Injectable Viscosupplementation for Joint by Country
    • 8.1.1 Middle East & Africa Injectable Viscosupplementation for Joint Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Injectable Viscosupplementation for Joint Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Injectable Viscosupplementation for Joint Sales by Type
  • 8.3 Middle East & Africa Injectable Viscosupplementation for Joint Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Injectable Viscosupplementation for Joint
  • 10.3 Manufacturing Process Analysis of Injectable Viscosupplementation for Joint
  • 10.4 Industry Chain Structure of Injectable Viscosupplementation for Joint

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Injectable Viscosupplementation for Joint Distributors
  • 11.3 Injectable Viscosupplementation for Joint Customer

12 World Forecast Review for Injectable Viscosupplementation for Joint by Geographic Region

  • 12.1 Global Injectable Viscosupplementation for Joint Market Size Forecast by Region
    • 12.1.1 Global Injectable Viscosupplementation for Joint Forecast by Region (2023-2028)
    • 12.1.2 Global Injectable Viscosupplementation for Joint Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Injectable Viscosupplementation for Joint Forecast by Type
  • 12.7 Global Injectable Viscosupplementation for Joint Forecast by Application

13 Key Players Analysis

  • 13.1 Sanofi
    • 13.1.1 Sanofi Company Information
    • 13.1.2 Sanofi Injectable Viscosupplementation for Joint Product Offered
    • 13.1.3 Sanofi Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Sanofi Main Business Overview
    • 13.1.5 Sanofi Latest Developments
  • 13.2 Anika Therapeutics
    • 13.2.1 Anika Therapeutics Company Information
    • 13.2.2 Anika Therapeutics Injectable Viscosupplementation for Joint Product Offered
    • 13.2.3 Anika Therapeutics Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Anika Therapeutics Main Business Overview
    • 13.2.5 Anika Therapeutics Latest Developments
  • 13.3 Seikagaku
    • 13.3.1 Seikagaku Company Information
    • 13.3.2 Seikagaku Injectable Viscosupplementation for Joint Product Offered
    • 13.3.3 Seikagaku Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Seikagaku Main Business Overview
    • 13.3.5 Seikagaku Latest Developments
  • 13.4 Zimmer Biomet
    • 13.4.1 Zimmer Biomet Company Information
    • 13.4.2 Zimmer Biomet Injectable Viscosupplementation for Joint Product Offered
    • 13.4.3 Zimmer Biomet Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Zimmer Biomet Main Business Overview
    • 13.4.5 Zimmer Biomet Latest Developments
  • 13.5 Bioventus
    • 13.5.1 Bioventus Company Information
    • 13.5.2 Bioventus Injectable Viscosupplementation for Joint Product Offered
    • 13.5.3 Bioventus Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Bioventus Main Business Overview
    • 13.5.5 Bioventus Latest Developments
  • 13.6 Ferring
    • 13.6.1 Ferring Company Information
    • 13.6.2 Ferring Injectable Viscosupplementation for Joint Product Offered
    • 13.6.3 Ferring Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Ferring Main Business Overview
    • 13.6.5 Ferring Latest Developments
  • 13.7 LG Chem
    • 13.7.1 LG Chem Company Information
    • 13.7.2 LG Chem Injectable Viscosupplementation for Joint Product Offered
    • 13.7.3 LG Chem Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 LG Chem Main Business Overview
    • 13.7.5 LG Chem Latest Developments
  • 13.8 Freda
    • 13.8.1 Freda Company Information
    • 13.8.2 Freda Injectable Viscosupplementation for Joint Product Offered
    • 13.8.3 Freda Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Freda Main Business Overview
    • 13.8.5 Freda Latest Developments
  • 13.9 Haohai Biological
    • 13.9.1 Haohai Biological Company Information
    • 13.9.2 Haohai Biological Injectable Viscosupplementation for Joint Product Offered
    • 13.9.3 Haohai Biological Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Haohai Biological Main Business Overview
    • 13.9.5 Haohai Biological Latest Developments
  • 13.10 Shanghai Jingfeng
    • 13.10.1 Shanghai Jingfeng Company Information
    • 13.10.2 Shanghai Jingfeng Injectable Viscosupplementation for Joint Product Offered
    • 13.10.3 Shanghai Jingfeng Injectable Viscosupplementation for Joint Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Shanghai Jingfeng Main Business Overview
    • 13.10.5 Shanghai Jingfeng Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Injectable Viscosupplementation for Joint. Industry analysis & Market Report on Injectable Viscosupplementation for Joint is a syndicated market report, published as Global Injectable Viscosupplementation for Joint Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Injectable Viscosupplementation for Joint market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,030.48
6,060.96
3,583.14
7,166.28
494,173.20
988,346.40
290,860.20
581,720.40
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report